Primary care education at UMass Chan Medical School is one of the best programs in the country, ranking in the top tier out of 99 medical schools according to U.S. News & World Report Best Graduate Schools 2025. Research at UMass Chan scored high on the report as well, ranking in the second of four tiers out of 102 medical schools for research activity and funding.
“I am deeply proud of our faculty and staff who ensure the next generation of physicians are educated to deliver high-quality, evidence-based, patient-centered care,” Chancellor Michael F. Collins said. “We know our graduates are exceptional; this annual high ranking helps inform prospective students. And our Nobel Prize-winning research enterprise is impacting health care and discovery in profound ways.”
UMass Chan has consistently been rated among the top medical schools for primary care education since U.S. News first published its rankings more than 25 years ago, reflecting the Medical School’s founding mission. This year, 60 students, or 43 percent of the T.H. Chan School of Medicine’s graduating class, matched into residencies in primary care and related specialties, including internal medicine, family medicine and pediatrics.
To continue to meet the growing need for physicians, the T.H. Chan School of Medicine increased its class size to 225 students and added a second regional campus. The new UMass Chan-Lahey campus in Burlington, established in partnership with Lahey Hospital & Medical Center, follows the core medical school curriculum with an added focus on leadership, health systems science and interprofessional education. UMass Chan-Lahey follows the success of UMass Chan’s regional campus at Baystate Health in Springfield, which is home to the Population-based Urban and Rural Community Health, or PURCH, track.
In addition to its educational mission, UMass Chan is a world-class research institution that attracted nearly $200 million in funding from the National Institutes of Health in fiscal year 2024, according to the Blue Ridge Institute for Biomedical Research.
A new 350,000-square-foot education and research building, opened in June and expected to be named the Paul J. DiMare Center, is home to investigators focused on accelerating research into new therapeutics for some of the most challenging diseases. The UMass Board of Trustees is scheduled to vote on the new name after the Paul J. DiMare Foundation committed $35 million to neurodegenerative and genetic disease research at UMass Chan to honor the legacy of Paul J. DiMare, a Massachusetts native, agricultural leader and philanthropist who was dedicated to supporting health and science.
